Has Assaf Berger, MD received payments from drug or device companies?

Yes. Drug and device makers reported $50,413 in general payments to Assaf Berger, MD across 91 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Assaf Berger, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Assaf Berger, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Assaf Berger, MD

Neurological Surgery · New York, NYNPI 1477226587

Payments from drug & device makers

What this record shows

This record is dominated by grants: $42,727 of the $50,413 with a category attached, or 84.8%. 12 manufacturers reported payments, led by Abbott at 49.2% of the total. Reporting peaked in 2022 at $42,940 and has fallen 89.2% since, to $4,623 in 2025.

$50,413in general payments, 2019–2025

Across 91 payments — averaging $553.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$25K
Medtronic$23K
Boston Scientific$787
Nevro Corp.$725
Globus Medical$474
Insightec,inc$227
plus $853 from 6 others

What the payments were for

Grants$42,72785%
Travel & lodging$3,5407%
Food & beverage$4,1468%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	28	$24,784
Medtronic	17	$22,563
Boston Scientific	12	$787
Nevro Corp.	14	$725
Globus Medical(2 entities)	8	$474
Insightec,inc	2	$227
Saluda Medical Americas, Inc.	3	$202
Clearpoint Neuro, Inc.	3	$191
Imperative Care, Inc	1	$161
Elekta, Inc.	1	$145
Nalu Medical, Inc.	1	$127
MML US, Inc.	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$50,413 in reported general payments places this provider in the 80th percentile of 446 neurological surgery providers in New York.

See all neurological surgery providers in New York →

Medicare billing

Part B allowed, 2024

$23,620

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in New York

J MoccoNew York$1.6M
Alejandro BerensteinNew York$1.1M
Darryl LauNew York$915K
Mark BilskyNew York$903K
Jan-Karl BurkhardtNew York$441K
Dean ChouNew York$383K
Reade DeleacyNew York$329K
Johanna FifiNew York$326K
David LangerNew York$258K
Ali BaajNew York$240K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →